Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome
Publication information:
Escande, Nin, Price N, Capellini, Gomes A, Barbosa M, O’Neil, White T, Sinclair D, Chini E. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.
Diabetes. 2013;62(4):1084–93.